In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michelle Duggan, Inward Investment Manager, Invest North East England.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Michelle, covering:
- Why is North East England becoming a UK hot spot for Health and Life Sciences.
- Collaborating and breaking down barriers to help create a super cluster of life sciences.
- The academic and industrial heartbeat that makes the region so attractive to CDMOs and major supply chain players.
Michelle Duggan has been an inward investment manager at invest North East England since January 2021. In 2016 to 2020 she was previously appointed as Partnership manager of Newcastle University where she was responsible for cultivating and maintaining relationships among business partners.
Her devotion to the North East is unmatched across her extensive career. With her other previous position as economic advisor at North East Local Enterprise Partnership she helped place where businesses invest, grow and prosper – delivering more and better jobs for everyone.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.
We are also proudly supported by Zymewire, which is the leader in actionable sales intelligence for life science Business development professionals. In fact, thousands of life science BD professionals start their day with sales signals from Zymewire. Learn more at tryzymewire.com